1. Home
  2. GNLN vs NEUP Comparison

GNLN vs NEUP Comparison

Compare GNLN & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLN
  • NEUP
  • Stock Information
  • Founded
  • GNLN 2005
  • NEUP 1996
  • Country
  • GNLN United States
  • NEUP United States
  • Employees
  • GNLN N/A
  • NEUP N/A
  • Industry
  • GNLN Durable Goods
  • NEUP
  • Sector
  • GNLN Consumer Discretionary
  • NEUP
  • Exchange
  • GNLN Nasdaq
  • NEUP Nasdaq
  • Market Cap
  • GNLN 12.9M
  • NEUP 12.7M
  • IPO Year
  • GNLN 2019
  • NEUP N/A
  • Fundamental
  • Price
  • GNLN $0.01
  • NEUP $7.01
  • Analyst Decision
  • GNLN
  • NEUP Strong Buy
  • Analyst Count
  • GNLN 0
  • NEUP 1
  • Target Price
  • GNLN N/A
  • NEUP $21.00
  • AVG Volume (30 Days)
  • GNLN 534.9M
  • NEUP 22.3K
  • Earning Date
  • GNLN 08-13-2025
  • NEUP 08-15-2025
  • Dividend Yield
  • GNLN N/A
  • NEUP N/A
  • EPS Growth
  • GNLN N/A
  • NEUP N/A
  • EPS
  • GNLN N/A
  • NEUP 0.00
  • Revenue
  • GNLN $9,818,000.00
  • NEUP $15,662,715.00
  • Revenue This Year
  • GNLN $1,541.21
  • NEUP N/A
  • Revenue Next Year
  • GNLN N/A
  • NEUP N/A
  • P/E Ratio
  • GNLN N/A
  • NEUP $4,149.50
  • Revenue Growth
  • GNLN N/A
  • NEUP N/A
  • 52 Week Low
  • GNLN $0.01
  • NEUP $2.90
  • 52 Week High
  • GNLN $21.80
  • NEUP $126.00
  • Technical
  • Relative Strength Index (RSI)
  • GNLN 28.32
  • NEUP N/A
  • Support Level
  • GNLN $0.01
  • NEUP N/A
  • Resistance Level
  • GNLN $0.02
  • NEUP N/A
  • Average True Range (ATR)
  • GNLN 0.00
  • NEUP 0.00
  • MACD
  • GNLN 0.00
  • NEUP 0.00
  • Stochastic Oscillator
  • GNLN 9.09
  • NEUP 0.00

About GNLN Greenlane Holdings Inc.

Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.

About NEUP Neuphoria Therapeutics Inc. Common Stock

Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.

Share on Social Networks: